Preview Mode Links will not work in preview mode

Oct 30, 2024

Practical Perspectives: Optimizing the Role of BTK Inhibitors in the Management of Mantle Cell Lymphoma | Faculty Presentation — Michael Wang, MD

CME information and select publications.


Oct 30, 2024

Featuring perspectives from Dr Tycel Phillips and Dr Michael Wang, including the following topics:

  • Introduction: Interface Between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma (0:00)
  • Key Datasets — Overview and First-Line Therapy (7:16)
  • Faculty Case Presentations — Dr Phillips (27:03)
  • Key Datasets —...


Oct 25, 2024

Featuring a slide presentation and related discussion from Dr Erika Hamilton, including the following topics:

  • Targeted therapies for ER-positive breast cancer (0:00)
  • Clinical data with oral selective estrogen receptor degraders (2:13)
  • Biological rationale for and mechanism of action of proteolysis-targeting chimeras...


Oct 25, 2024

Featuring an interview with Dr Erika Hamilton, including the following topics:

  • Pathophysiology and pharmacology of ER-positive breast cancer treatment (0:00)
  • Clinical evidence available with oral selective estrogen receptor degraders (3:46)
  • Mechanism of action of proteolysis-targeting chimeras (PROTACs) (13:22)
  • PROTACs...


Oct 24, 2024

Practical Perspectives: Current Management of Chronic Myeloid Leukemia | Faculty Presentation — Jorge Cortes, MD 

CME information and select publications